July 22, 2014 8:22 PM ET

Healthcare Equipment and Supplies

Company Overview of China Medical Technologies Inc.

Company Overview

China Medical Technologies, Inc., a medical device company, develops, manufactures, and markets immunodiagnostic and molecular diagnostic products. It uses molecular diagnostic technologies, including fluorescent in situ hybridization (FISH) and surface plasmon resonance (SPR), and enhanced chemiluminescence immunoassay (ECLIA), an immunodiagnostic technology in the development, manufacturing, and distribution of diagnostic products for the detection of various cancers, diseases, and disorders, as well as companion diagnostic tests for targeted cancer drugs. The company offers immunodiagnostic products, such as ECLIA analyzers and reagent kits for various clinical applications, including ane...

No 24 Yong Chang North Road

Beijing Economic-Technological Development Area

Beijing,  100176

China

Founded in 1999

971 Employees

Phone:

86 10 6787 1166

Fax:

86 10 6788 9588

Key Executives for China Medical Technologies Inc.

Founder
Age: 58
Chief Financial Officer
Age: 43
Senior Vice President of Operations
Age: 45
Chief Technology Officer
Age: 49
Senior Researcher of YDME Beijing
Compensation as of Fiscal Year 2014.

China Medical Technologies Inc. Key Developments

SEC Revokes Registration Of Registered Securities Of China Medical Technologies

The registration of the registered securities of China Medical Technologies Inc., has been revoked. It failed to comply with reporting requirements of the Securities Exchange Act of 1934. Thus, it violated a crucial provision of the federal securities laws that requires public corporations to publicly disclose current, accurate financial information so that investors may make informed decisions. The revocation was ordered in an administrative proceeding before an administrative law judge.

SEC Orders Hearing On Registration Suspension Or Revocation Against China Medical Technologies

The Securities and Exchange Commission (SEC) announced the issuance of an Order Instituting Proceedings and Notice of Hearing Pursuant to Section 12(j) of the Securities Exchange Act of 1934 (Order) against China Medical Technologies, Inc. The Order alleges that the Company has failed to file an annual report for the year ended March 31, 2012 in violation of Section 13(a) of the Exchange Act and rule 13a-1 there under. A hearing will be held by an Administrative Law Judge to determine whether the allegations contained in the Order are true, to afford the Company an opportunity to establish any defenses to such allegations, and to determine whether it is necessary or appropriate for the protection of investors to suspend for a period not exceeding twelve months, or revoke the registration of each class of securities of the Company registered pursuant to Section 12 of the Securities Exchange Act of 1934. The Order requires the Administrative Law Judge to issue an initial decision no later than 120 days from the date of service of this Order, pursuant to Rule 360(a)(2) of the Commission's Rules of Practice.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact China Medical Technologies Inc., please visit www.chinameditech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.